ctrl K

Watchlist Price Alert

iTeos Therapeutics Inc. (ITOS)

NASDAQ: ITOS · Real-Time Price · USD

7.73

0.13 (1.71%)

At close: May 15, 2025, 9:59 AM

iTeos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	35M	12.6M	267.63M	344.77M	n/a	n/a	n/a
Cost of Revenue	1.24M	898K	813K	615K	535K	611K	505K
Gross Profit	33.76M	11.7M	266.82M	344.16M	-535K	-611K	-505K
Operating Income	-159.53M	-151.1M	126.32M	244.9M	-45.24M	-28.05M	-21.5M
Interest Income	30.87M	31.77M	11.36M	78K	n/a	n/a	n/a
Pretax Income	-120.34M	-109.03M	148.74M	256.46M	-38.09M	-22.34M	-18.05M
Net Income	-134.41M	-112.64M	96.65M	214.52M	-38.03M	-22.45M	-18.06M
Selling & General & Admin	49.08M	50.4M	43.95M	40.51M	15.34M	8.84M	4.31M
Research & Development	145.45M	113.3M	97.36M	59.37M	29.9M	19.21M	17.19M
Other Expenses	n/a	n/a	-3.26M	-10.18M	-5.93M	-4.78M	-163K
Operating Expenses	194.53M	163.7M	138.04M	89.69M	39.31M	23.27M	17.82M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	66K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	194.53M	163.7M	138.04M	89.69M	39.31M	23.27M	17.82M
Income Tax Expense	14.07M	3.61M	52.08M	41.94M	-57K	119K	11K
Shares Outstanding (Basic)	40.47M	35.76M	35.55M	35.18M	35.04M	35.02M	7.51M
Shares Outstanding (Diluted)	40.47M	35.76M	37.77M	37.77M	35.04M	35.02M	7.51M
EPS (Basic)	-3.32	-3.15	2.72	6.10	-1.09	-0.64	-2.4
EPS (Diluted)	-3.32	-3.15	2.56	5.68	-1.09	-0.64	-2.4
EBITDA	-159.53M	-151.1M	148.38M	257.08M	-37.84M	-21.72M	-17.48M
EBIT	-154.32M	-144.89M	147.56M	256.46M	-38.38M	-23.13M	-18.74M
Depreciation & Amortization	1.24M	898K	813K	615K	535K	611K	505K